Literature DB >> 33408231

Monitoring COVID-19 Transmission Risks by Quantitative Real-Time PCR Tracing of Droplets in Hospital and Living Environments.

Andrea Piana1, Maria Eugenia Colucci2, Federica Valeriani3, Adriano Marcolongo4, Giovanni Sotgiu1, Cesira Pasquarella2, Lory Marika Margarucci3, Andrea Petrucca4, Gianluca Gianfranceschi3, Sergio Babudieri1, Pietro Vitali2, Giuseppe D'Ermo5, Assunta Bizzarro2, Flavio De Maio6, Matteo Vitali7, Antonio Azara1, Ferdinando Romano7, Maurizio Simmaco4, Vincenzo Romano Spica8.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination occurs through droplets and biological fluids released in the surroundings from patients or asymptomatic carriers. Surfaces and objects contaminated by saliva or nose secretions represent a risk for indirect transmission of coronavirus disease 2019 (COVID-19). We assayed surfaces from hospital and living spaces to identify the presence of viral RNA and the spread of fomites in the environment. Anthropic contamination by droplets and biological fluids was monitored by detecting the microbiota signature using multiplex quantitative real-time PCR (qPCR) on selected species and massive sequencing on 16S amplicons. A total of 92 samples (flocked swabs) were collected from critical areas during the pandemic, including indoor (three hospitals and three public buildings) and outdoor surfaces exposed to anthropic contamination (handles and handrails, playgrounds). Traces of biological fluids were frequently detected in spaces open to the public and on objects that are touched with the hands (>80%). However, viral RNA was not detected in hospital wards or other indoor and outdoor surfaces either in the air system of a COVID hospital but only in the surroundings of an infected patient, in consistent association with droplet traces and fomites. Handled objects accumulated the highest level of multiple contaminations by saliva, nose secretions, and fecal traces, further supporting the priority role of handwashing in prevention. In conclusion, anthropic contamination by droplets and biological fluids is widespread in spaces open to the public and can be traced by qPCR. Monitoring fomites can support evaluation of indirect transmission risks for coronavirus or other flu-like viruses in the environment.IMPORTANCE Several studies have evaluated the presence of SARS-CoV-2 in the environment. Saliva and nasopharyngeal droplets can land on objects and surfaces, creating fomites. A suitable indicator would allow the detection of droplets or biofluids carrying the virus. Therefore, we searched for viral RNA and droplets and fomites on at risk surfaces. We monitored by qPCR or next generation sequencing (NGS) droplets through their microbiota. Although the study was performed during the pandemic, SARS-CoV-2 was not significantly found on surfaces, with the only exception of environmental areas near infectious patients. Conversely, anthropic contamination was frequent, suggesting a role for biofluids as putative markers of indirect transmission and risk assessment. Moreover, all SARS-CoV-2-contaminated surfaces showed droplets' microbiota. Fomite monitoring by qPCR may have an impact on public health strategies, supporting prevention of indirect transmission similarly to what is done for other communicable diseases (e.g., influenza and influenza-like infections).
Copyright © 2021 Piana et al.

Entities:  

Keywords:  SARS-CoV-2; biological fluids; droplets; environmental contamination; fomite; microbiota

Mesh:

Substances:

Year:  2021        PMID: 33408231      PMCID: PMC7845593          DOI: 10.1128/mSphere.01070-20

Source DB:  PubMed          Journal:  mSphere        ISSN: 2379-5042            Impact factor:   4.389


  59 in total

Review 1.  Overview of Next-Generation Sequencing Technologies.

Authors:  Barton E Slatko; Andrew F Gardner; Frederick M Ausubel
Journal:  Curr Protoc Mol Biol       Date:  2018-04

2.  Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals.

Authors:  Yuan Liu; Zhi Ning; Yu Chen; Ming Guo; Yingle Liu; Nirmal Kumar Gali; Li Sun; Yusen Duan; Jing Cai; Dane Westerdahl; Xinjin Liu; Ke Xu; Kin-Fai Ho; Haidong Kan; Qingyan Fu; Ke Lan
Journal:  Nature       Date:  2020-04-27       Impact factor: 49.962

3.  Usefulness of Multiplex Real-Time PCR for Simultaneous Pathogen Detection and Resistance Profiling of Staphylococcal Bacteremia.

Authors:  Yousun Chung; Taek Soo Kim; Young Gi Min; Yun Ji Hong; Jeong Su Park; Sang Mee Hwang; Kyoung-Ho Song; Eu Suk Kim; Kyoung Un Park; Hong Bin Kim; Junghan Song; Eui-Chong Kim
Journal:  Biomed Res Int       Date:  2016-06-15       Impact factor: 3.411

4.  Aerosol and environmental surface monitoring for SARS-CoV-2 RNA in a designated hospital for severe COVID-19 patients.

Authors:  Y H Li; Y Z Fan; L Jiang; H B Wang
Journal:  Epidemiol Infect       Date:  2020-07-14       Impact factor: 2.451

Review 5.  SARS-CoV-2 from faeces to wastewater treatment: What do we know? A review.

Authors:  Paola Foladori; Francesca Cutrupi; Nicola Segata; Serena Manara; Federica Pinto; Francesca Malpei; Laura Bruni; Giuseppina La Rosa
Journal:  Sci Total Environ       Date:  2020-06-24       Impact factor: 7.963

6.  Simultaneous amplicon sequencing to explore co-occurrence patterns of bacterial, archaeal and eukaryotic microorganisms in rumen microbial communities.

Authors:  Sandra Kittelmann; Henning Seedorf; William A Walters; Jose C Clemente; Rob Knight; Jeffrey I Gordon; Peter H Janssen
Journal:  PLoS One       Date:  2013-02-08       Impact factor: 3.240

7.  What does it take to satisfy Koch's postulates two centuries later? Microbial genomics and Propionibacteria acnes.

Authors:  Julia A Segre
Journal:  J Invest Dermatol       Date:  2013-07-11       Impact factor: 8.551

Review 8.  The healthy human microbiome.

Authors:  Jason Lloyd-Price; Galeb Abu-Ali; Curtis Huttenhower
Journal:  Genome Med       Date:  2016-04-27       Impact factor: 11.117

9.  Environmental virus detection associated with asymptomatic SARS-CoV-2-infected individuals with positive anal swabs.

Authors:  Ying Huang; Zhen Ding; Qi Chen; Ling Wu; Lili Guo; Chunhua Zhao; Li Sha; Hong Sun
Journal:  Sci Total Environ       Date:  2020-09-09       Impact factor: 7.963

Review 10.  Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination.

Authors:  J A Otter; C Donskey; S Yezli; S Douthwaite; S D Goldenberg; D J Weber
Journal:  J Hosp Infect       Date:  2015-10-03       Impact factor: 3.926

View more
  5 in total

1.  Monitoring SARS-CoV-2 in air and on surfaces and estimating infection risk in buildings and buses on a university campus.

Authors:  Xin Zhang; Jianfeng Wu; Lauren M Smith; Xin Li; Olivia Yancey; Alfred Franzblau; J Timothy Dvonch; Chuanwu Xi; Richard L Neitzel
Journal:  J Expo Sci Environ Epidemiol       Date:  2022-04-27       Impact factor: 6.371

Review 2.  Testing at scale during the COVID-19 pandemic.

Authors:  Tim R Mercer; Marc Salit
Journal:  Nat Rev Genet       Date:  2021-05-04       Impact factor: 59.581

3.  Low risk of SARS-CoV-2 transmission via fomite, even in cold-chain.

Authors:  Julia S Sobolik; Elizabeth T Sajewski; Lee-Ann Jaykus; D Kane Cooper; Ben A Lopman; Alicia Nm Kraay; P Barry Ryan; Jodie L Guest; Amy Webb-Girard; Juan S Leon
Journal:  medRxiv       Date:  2021-08-26

4.  Potential risk of SARS-CoV-2 infection among people handling linens used by COVID-19 patients before and after washing.

Authors:  Retsu Fujita; Hitomi Kurosu; Masataro Norizuki; Takayuki Ohishi; Aya Zamoto-Niikura; Masaaki Iwaki; Keiko Mochida; Hirotaka Takagi; Toshihiko Harada; Kenji Tsushima; Tetsuya Matsumoto; Ken-Ichi Hanaki; Motoyuki Sugai; Takuya Yamagishi
Journal:  Sci Rep       Date:  2022-09-02       Impact factor: 4.996

5.  Feasibility and utility of facemask sampling in the detection of SARS-CoV-2 during an ongoing pandemic.

Authors:  Dorothy Hui Lin Ng; Mei Yi Sim; Hong Hong Huang; Jean Xiang Ying Sim; Jenny Guek Hong Low; Jay Kheng Sit Lim
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-07-05       Impact factor: 3.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.